Relationship between YKL-40 and pulmonary arterial hypertension in systemic sclerosis

References

• Shuhui L, Mok YK, Wong WS. Role of mammalian chitinases in asthma. Int Arch Allergy Immunol. 2009;149(4):369–77.
   PubMed Web of Science ®Google Scholar
• Renkema GH, Boot RG, Au FL, Donker-Koopman WE, Strijland A, Muijsers AO, et al. Chitoriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur J Biochem. 1998;251(1–2):504–9.
   PubMedGoogle Scholar
• Chupp GL, Lee CG, Jarjour N, Shim YM, Holm CT, He S, et al. A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med. 2007;357(20):2016–27.
   PubMed Web of Science ®Google Scholar
• Tang H, Fang Z, Sun Y, Li B, Shi Z, Chen J, et al. YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E. Eur Respir J. 2010;35(4):757–60.
   PubMed Web of Science ®Google Scholar
• Schultz NA, Johansen JS. YKL-40-A protein in the field of translational medicine: A role as a biomarker in cancer patients? Cancers (Basel). 2010;2(3):1453–91.
   PubMedGoogle Scholar
• Shao R, Taylor SL, Oh DS, Schwartz LM. Vascular heterogeneity and targeting: The role of YKL-40 in glioblastoma vascularization. Oncotarget 2015;6(38):40507–18.
   PubMedGoogle Scholar
• Shao R, Francescone R, Ngernyuang N, Bentley B, Taylor SL, Moral L, Yan W. Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma. Carcinogenesis. 2014;35(2):373–82.
   PubMed Web of Science ®Google Scholar
• De Ceuninck F, Gaufillier S, Bonnaud A, Sabatini M, Lesur C, Pastoureau P. YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys Res Commun. 2001;285(4):926–31.
   PubMed Web of Science ®Google Scholar
• Turkyilmaz AK, Devrimsel G, Kirbas A, Cicek Y, Karkucak M, Capkin E, Gokmen F. Relationship between pulse wave velocity and serum YKL-40 level in patients with early rheumatoid arthritis. Rheumatol Int. 2013;33(11):2751–6.
   PubMed Web of Science ®Google Scholar
• Vind I, Johansen JS, Price PA, Munkholm P. Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease. Scand J Gastroenterol. 2003;38(6):599–605.
   PubMed Web of Science ®Google Scholar
• Imai Y, Aochi S, Iwatsuki K, Sano H, Yamanishi K. YKL-40 (chitinase 3-like 1) as a biomarker for psoriasis vulgaris and pustular psoriasis. J Dermatol Sci. 2011;64:75–7.
   PubMed Web of Science ®Google Scholar
• Imai Y, Aochi S, Iwatsuki K, Sano H, Yamanishi K. YKL-40 is a serum biomarker reflecting the severity of cutaneous lesions in psoriatic arthritis. J Dermatol. 2013;40(4):294–6.
   PubMed Web of Science ®Google Scholar
• Johansen JS, Christoffersen P, Møller S, Price PA, Henriksen JH, Garbarsch C, Bendtsen F. Serum YKL-40 is increased in patients with hepatic fibrosis. J Hepatol. 2000;32(6):911–20.
   PubMed Web of Science ®Google Scholar
• Chen G, Yang T, Gu Q, Ni X-H, Zhao Z-H, Ye J, et al. Elevated plasma YKL-40 as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension. Respirol. 2014;19(4):608–15.
   PubMed Web of Science ®Google Scholar
• Recklies AD, White C, Ling H. H. The chitinase 3-like protein human cartilage 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase and protein kinase B-mediated signaling pathways. Biochem J. 2002;365(1):119–26.
   PubMedGoogle Scholar
• Nordenbaek C, Johansen JS, Halberg P, Wiik A, Garbarsch C, Ullman S, et al. High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement. Scand J Rheumatol. 2005;34(4):293–7.
   PubMed Web of Science ®Google Scholar
• Nishikawa KC, Millis AJT. Gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells. Exp Cell Res. 2003;287(1):79–97.
   PubMed Web of Science ®Google Scholar
• La Montagna G, D’Angelo S, Valentini G. Cross-sectional evaluation of YKL-40 serum concentrations in patients with systemic sclerosis. Relationship with clinical and serological aspects of disease. J Rheumatol. 2003;30:2147–51.
   PubMed Web of Science ®Google Scholar
• Bonella F, Costabel U. Biomarkers in connective tissue disease-associated interstitial lung disease. Semin Respir Crit Care Med. 2014;35(2):181–200.
   PubMed Web of Science ®Google Scholar
• van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: An American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737–47.
   PubMed Web of Science ®Google Scholar
• Morrisroe K, Stevens W, Huq M, Prior D, Sahhar J, Ngian G-S, et al. Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension. Arthritis Res Ther. 2017;19(1):122.
   PubMedGoogle Scholar
• Gao J, Iwamoto H, Koskela J, Alenius H, Hattori N, Kohno N, et al. Characterization of sputum biomarkers for asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2016;11:2457–65.
   PubMed Web of Science ®Google Scholar
• Tatar E, Gungor O, Celtik A, Sisman AR, Yaprak M, Asci G, et al. Correlation between serum YKL-40 (chitinase-3-like protein 1) level and proteinuria in renal transplant recipients. Ann Transplant. 2013;18:95–100.
   PubMed Web of Science ®Google Scholar
• Bojesen SE, Johansen JS, Nordestgaard BG. Plasma YKL-40 levels in healthy subjects from the general population. Clin Chim Acta. 2011;412(9–10):709–12.
   PubMed Web of Science ®Google Scholar
• Johansen JS, Baslund B, Garbarsch C, Hansen M, Stoltenberg M, Lorenzen IB, et al. YKL-40 in giant cells and macrophages from patients with giant cell arteritis. Arthritis Rheum. 1999;42(12):2624–30.
   PubMedGoogle Scholar
• Hassoun PM. The right ventricle in scleroderma (2013 Grover Conference Series). Pulm Circ. 2015;5(1):3–14.
   PubMed Web of Science ®Google Scholar
• Grigoryev DN, Mathai SC, Fisher MR, Girgis RE, Zaiman AL, Housten-Harris T, et al. Identification of candidate genes in scleroderma-related pulmonary arterial hypertension. Transl Res. 2008;151(4):197–207.
   PubMed Web of Science ®Google Scholar
• Francescone RA, Scully S, Faibish M, Taylor SL, Oh D, Moral L, et al. Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma. J Biol Chem. 2011;286(17):15332–43.
   PubMed Web of Science ®Google Scholar
• Allanore Y, Borderie D, Avouac J, Zerkak D, Meune C, Hachulla E, et al. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. Arthritis Rheum. 2008;58(1):284–91.
   PubMed Web of Science ®Google Scholar
• Wang B, Feng Y, Jia LQ, Wu XL, Li DD, Zhou HX, et al. Accuracy of Doppler echocardiography in the assessment of pulmonary arterial hypertension in patients with congenital heart disease. Eur Rev Med Pharmacol Sci. 2013;17:923–8.
   PubMed Web of Science ®Google Scholar